Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NC 4.0Diagnostic and Interventional Radiology

Comparative evaluation of two resorbable microparticles in a porcine kidney model: angiographic and pathologic outcomes

6 affiliations
  1. 1Seoul National University Bundang Hospital, Department of Radiology, Seongnam, Republic of Korea
  2. 2Jeonbuk National University Faculty of Medicine, Department of Radiology, Jeonju, Republic of Korea
  3. 3Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea
  4. 4Seoul Metropolitan Government, Seoul National University Boramae Medical Center, Department of Radiology, Seoul, Republic of Korea
  5. 5Seoul National University Bundang Hospital, Department of Plastic and Reconstructive Surgery, Seongnam, South Korea
  6. 6Seoul National University College of Medicine, Department of Radiology, Seoul, Republic of Korea

Abstract

PURPOSE: This study aimed to compare the safety and efficacy of two resorbable microparticles in a porcine kidney model, focusing on recanalization and tissue injury outcomes over a 7-day follow-up period.

METHODS: This exploratory proof-of-concept study included 10 pigs, each undergoing embolization of the upper polar arteries in both kidneys, resulting in 20 treated kidneys (10 per group). Angiographic evaluations were performed on all 20 treated kidneys (10 per group) across the 10 animals at immediate, 2-hour, 1-day, and 7-day post-embolization time points. Histopathologic evaluations were performed on 5 animals per group (5 kidneys per group). The primary endpoint was complete angiographic recanalization at 7 days. Secondary endpoints included early recanalization at 2 hours and 1 day and histopathologic tissue injury. In Group A, the right upper polar artery was embolized with spherical gelatin microparticles (Nexsphere-F®), whereas in Group B, the left upper polar artery was embolized with irregular microparticles (KIPZA®). Approximately 5–10 mL of microparticle suspension was injected per kidney; the mean embolization time per kidney was 30 ± 5 minutes.

RESULTS: At 2 hours post-embolization, complete recanalization was observed in all Nexsphere-F kidneys and in 9 of 10 KIPZA kidneys; 1 KIPZA kidney showed partial recanalization. Full recanalization was observed in all kidneys by day 7. Histopathologic evaluation (5 kidneys per group) revealed no residual emboli or parenchymal infarction in Group A. In Group B, minimal microparticle residue and focal infarction (mean infarcted area 2.78% ± 1.33%) were observed, along with endothelial proliferation in arcuate and interlobular arteries.

CONCLUSION: In this exploratory pilot study, embolization with both Nexsphere-F and KIPZA microparticles resulted in early recanalization and minimal tissue injury. These proof-of-concept findings suggest that both microparticles may be suitable for temporary embolization when organ preservation is paramount, although larger powered studies with disease models and longer follow-up are needed.

CLINICAL SIGNIFICANCE: These preliminary data support the potential of resorbable microparticles for temporary embolization, emphasizing their use in scenarios requiring parenchymal preservation and underscoring the need for further research.

Related

  1. Evaluation of an Artificial Intelligence and Machine Learning Algorithm to Enhance Angiographic Coronary Visibility in Morbid Obesity: A Retrospective Observational Study
    Samia Mazumder, Tim Joseph, Devraj Sukul +5
    Journal of the Society for Cardiovascular Angiography & InterventionsPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyPMCEurope PMC
  2. Clinico-pathologic Evaluation of Patients with Hemangioendothelioma: A 10-year Experience from Shiraz, Southern of Iran
    Mohammad Hossein Anbardar, Mohammad Ali Rahmani, Ali Ameli +3
    Galen Medical JournalPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Dissolving hyaluronic acid microparticles improve skin barrier function, hydration, and elasticity in a randomized split-face clinical trial
    Hyunho Hwang, JinHee Koh, Huisuk Yang +6
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyCrossref
  4. Comparative Evaluation of Large Language Model Interfaces in Third Molar Surgery Complication Scenarios: Response Quality, Clinical Content, Potential Clinical Risk, Readability, and Externally Observable Response Latency—A Cross-Sectional Comparative Benchmark Study
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Coronary Drug-Coated Balloons as Brief-Contact Drug-Delivery Platforms: Engineering, Tissue Pharmacokinetics, and Angiographic/Imaging Response
    Grigorios Tsigkas, Antonios Rigas Papapanagiotou, Aggelos Papanikolaou +10
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{choi2026comparative,
  title = {{Comparative evaluation of two resorbable microparticles in a porcine kidney model: angiographic and pathologic outcomes}},
  author = {Won Seok Choi and Kun Yung Kim and Chong-ho Lee and Young-Min Han and Minuk Kim and Sung-hwan Yoon and Chang Jin Yoon and Jae Hwan Lee},
  journal = {Diagnostic and Interventional Radiology},
  year = {2026},
  month = nov,
  doi = {10.4274/dir.2026.263960},
  url = {https://doi.org/10.4274/dir.2026.263960},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Comparative evaluation of two resorbable microparticles in a porcine kidney model: angiographic and pathologic outcomes
AU  - Won Seok Choi
AU  - Kun Yung Kim
AU  - Chong-ho Lee
AU  - Young-Min Han
AU  - Minuk Kim
AU  - Sung-hwan Yoon
AU  - Chang Jin Yoon
AU  - Jae Hwan Lee
PY  - 2026
DA  - 2026/11/02
JO  - Diagnostic and Interventional Radiology
DO  - 10.4274/dir.2026.263960
UR  - https://doi.org/10.4274/dir.2026.263960
AB  - PURPOSE: This study aimed to compare the safety and efficacy of two resorbable microparticles in a porcine kidney model, focusing on recanalization and tissue injury outcomes over a 7-day follow-up period.  METHODS: This exploratory proof-of-concept study included 10 pigs, each undergoing embolization of the upper polar arteries in both kidneys, resulting in 20 treated kidneys (10 per group). Angiographic evaluations were performed on all 20 treated kidneys (10 per group) across the 10 animals at immediate, 2-hour, 1-day, and 7-day post-embolization time points. Histopathologic evaluations were performed on 5 animals per group (5 kidneys per group). The primary endpoint was complete angiographic recanalization at 7 days. Secondary endpoints included early recanalization at 2 hours and 1 day and histopathologic tissue injury. In Group A, the right upper polar artery was embolized with spherical gelatin microparticles (Nexsphere-F®), whereas in Group B, the left upper polar artery was embolized with irregular microparticles (KIPZA®). Approximately 5–10 mL of microparticle suspension was injected per kidney; the mean embolization time per kidney was 30 ± 5 minutes.  RESULTS: At 2 hours post-embolization, complete recanalization was observed in all Nexsphere-F kidneys and in 9 of 10 KIPZA kidneys; 1 KIPZA kidney showed partial recanalization. Full recanalization was observed in all kidneys by day 7. Histopathologic evaluation (5 kidneys per group) revealed no residual emboli or parenchymal infarction in Group A. In Group B, minimal microparticle residue and focal infarction (mean infarcted area 2.78% ± 1.33%) were observed, along with endothelial proliferation in arcuate and interlobular arteries.  CONCLUSION: In this exploratory pilot study, embolization with both Nexsphere-F and KIPZA microparticles resulted in early recanalization and minimal tissue injury. These proof-of-concept findings suggest that both microparticles may be suitable for temporary embolization when organ preservation is paramount, although larger powered studies with disease models and longer follow-up are needed.  CLINICAL SIGNIFICANCE: These preliminary data support the potential of resorbable microparticles for temporary embolization, emphasizing their use in scenarios requiring parenchymal preservation and underscoring the need for further research.
SN  - 1305-3825
SN  - 1305-3612
ER  -